首页|CXC趋化因子受体4在甲状腺癌中表达变化及与患者预后和免疫浸润的关系

CXC趋化因子受体4在甲状腺癌中表达变化及与患者预后和免疫浸润的关系

扫码查看
目的 探讨CXC趋化因子受体4(CXCR4)在甲状腺癌中表达变化及与患者预后和免疫浸润的关系.方法 选取2020年1月至2022年1月山东省烟台市烟台山医院收治的98例甲状腺癌组织和癌旁组织作为研究对象,采用荧光定量聚合酶链反应(PCR)和蛋白质免疫印迹分析癌旁组织和甲状腺癌组织CXCR4 mRNA和蛋白质表达水平.采用Oncomine数据库、Kaplan_meier Plotter数据库、TIMER数据库分析CXCR4基因表达与甲状腺癌免疫细胞浸润以及预后的关系.组间计量数据比较采用独立样本t检验.结果 癌旁组织CXCR4 mRNA表达水平(1.05±0.20)明显低于甲状腺癌组织(2.00±0.22),差异用统计学意义(t=31.480,P<0.05).癌旁组织CXCR4 mRNA表达水平(0.69±0.25)明显低于甲状腺癌组织(1.45±0.24),差异用统计学意义(t=21.550,P<0.05).数据库大量本分析结果显示癌旁组织中CXCR4 mRNA表达水平(1.57±0.52)明显低于甲状腺癌组织(3.41±0.68),差异用统计学意义(t=8.914,P<0.05).CXCR4基因表达与激活自然杀伤细胞和M0型巨噬细胞比例呈正相关(r=0.498、0.399,P<0.05).CXCR4基因表达与静息状态自然杀伤细胞比例、静息状态记忆CD4 T淋巴细胞、静息肥大细胞和单核细胞比例呈负相关(r=-1.524、-1.948、-3.102、-2.145,P<0.05).CXCR4 高表达甲状腺癌患者总生存时间[(12.52±3.14)个月]明显低于CXCR4低表达者[(22.41±4.56)个月],差异有统计学意义(Log-Rank=3.108,P<0.05).结论 CXCR4 mRNA和蛋白质在甲状腺癌组织中表达显著增加,并与患者免疫细胞浸润密切相关,CXCR4表达越高,患者预后越差.
Expression of CXC chemokine receptor 4 in thyroid cancer and its relationship with prognosis and immune invasion
Objective To investigate the expression of C-X-C chemokine receptor type 4(CXCR4)in thyroid cancer and its relationship with prognosis and immune invasion.Methods 98 cases of thyroid cancer and adjacent tissues treated from January 2020 to January 2022 in Yantai Mountain Hospi-tal of Shandong were selected as the study objects,and CXCR4 mRNA and protein expression levels in ad-jacent tissues and thyroid cancer tissues were analyzed by fluorescent quantitative polymerase chain reaction(PCR)and Western blotting.Oncomine database,Kaplan_meier Plotter database and TIMER database were used to analyze the relationship between CXCR4 gene expression and immune cell invasion and prog-nosis of thyroid cancer.Independent sample t test was used to compare the measurement data between groups.Results The mRNA expression level of CXCR4 in para-carcinoma tissues(1.05±0.20)was sig-nificantly lower than that in thyroid cancer tissues(2.00±0.22,t=31.480,P<0.05).The mRNA ex-pression level of CXCR4 in paracancer tissues(0.69±0.25)was significantly lower than that in thyroid cancer tissues(1.45±0.24,t=21.550,P<0.05).The results of a large number of analyses in the data-base showed that the mRNA expression level of CXCR4 in adjacent tissues(1.57±0.52)was significantly lower than that in thyroid cancer tissues(3.41±0.68),and the difference was statistically significant(t=8.914,P<0.05).CXCR4 gene expression was correlated with the proportion of activated natural killer cells and M0 macrophages(r=0.498,0.399,P<0.05).CXCR4 gene expression was negatively correla-ted with the proportion of resting state natural killer cells,resting state memory CD4 T lymphocytes,resting mast cells and monocytes(r=-1.524,-1.948,-3.102,-2.145,P<0.05).The overall survival time of thyroid cancer patients with high CXCR4 expression[(12.52±3.14)months]was significantly lower than that of thyroid cancer patients with low CXCR4 expression[(22.41±4.56)months],and the difference was statistically significant(Log-Rank=3.108,P<0.05).Conclusion The expression of CXCR4 mRNA and protein is significantly increased in thyroid cancer tissues,and is closely related to im-mune cell infiltration in patients.The higher the expression of CXCR4,the worse the prognosis of patients.

CXC chemokine receptor 4Thyroid cancerPrognosisImmunoinfiltration

朱厚圩、郭向林、朱于临

展开 >

山东省烟台市烟台山医院甲状腺外科,烟台 264003

山东省烟台市烟台山医院麻醉科,烟台 264003

CXC趋化因子受体4 甲状腺癌 预后 免疫浸润

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(12)